Balanced product information
Evidence, limitations and safety — in one consistent format.
This page separates authorised uses from investigational or reported uses. It does not provide personal medical advice or dosing instructions.
Product name
Biotin (vitamin B7)
Catalogue label details describe what is displayed; they do not independently verify composition, quality, batch release or UK marketing authorisation.
What is it?
Biotin is a water-soluble B vitamin that the body uses as a cofactor for enzymes involved in fat, carbohydrate and amino-acid metabolism.
The 40mg injection pen shown here is a high-dose presentation. Its route, formulation and quality cannot be inferred from ordinary food intake or licensed oral supplements.
Intended / recognised uses
Authorised / recognised uses
- Biotin may be used under specialist care for confirmed deficiency and certain rare inherited metabolic disorders.
- The indication and formulation depend on the diagnosed condition and applicable product information.
Reported / other uses
- Biotin is widely promoted for hair, skin and nails, but evidence of benefit in people without deficiency is limited.
- No established clinical advantage has been verified for this high-dose injectable presentation.
How it works
Biotin supports carboxylase enzymes needed for normal energy metabolism and synthesis of fatty acids and glucose.
Correcting true deficiency restores these enzyme functions; taking more than required does not automatically produce additional cosmetic or metabolic benefit.
Potential benefits / effects
- Treatment can correct clinical and biochemical effects of genuine biotin deficiency.
- Claims for stronger hair, nails, skin or general energy in non-deficient people are not supported by robust evidence for this injection.
Potential benefit is not a guarantee of benefit for any individual.
Risks & warnings
- High biotin exposure can interfere with laboratory immunoassays and produce falsely high or low results, including some thyroid, hormone and cardiac troponin tests.
- Misleading results can delay diagnosis or lead to inappropriate treatment; this is a major safety issue even when the person feels well.
- Injection adds risks of local injury, infection, allergy and formulation uncertainty.
Possible side effects
Known or possible effects
- Reliable frequency data are not available for this exact injection. Local pain, redness, swelling, nausea or headache may occur.
- Laboratory-test interference may cause no physical symptom but can have serious clinical consequences.
Serious or urgent concerns
- Breathing difficulty, facial swelling or a severe injection-site reaction requires urgent care.
- Anyone having urgent blood tests should tell the treating team about biotin exposure immediately.
Who should not use it / precautions
- People due to have blood tests, or being assessed for chest pain, thyroid disease, fertility, hormone disorders or other conditions measured by immunoassay, must disclose biotin use.
- Pregnancy, breastfeeding, childhood, kidney disease, rare metabolic disease and previous injection allergy require professional advice.
- Stopping or timing biotin before a test should be decided by the clinician or laboratory, not by this website.
Interactions
- The most important interaction is with laboratory tests rather than a conventional drug–drug interaction.
- Some long-term medicines, including certain anti-seizure treatments, can affect biotin status, while the clinical significance varies.
- A pharmacist should review the full medicine and supplement list.
Regulatory / legal status
- Biotin is a nutrient, but high-dose injection products can fall within medicines regulation depending on presentation and intended use.
- The HELIX 40mg injection pen has not been verified here as a UK-authorised medicinal product; nutrient status does not make an injectable product automatically licensed or safe.
Monitoring / professional supervision
- Confirmed deficiency or a rare metabolic disorder should be diagnosed and monitored by an appropriate specialist.
- Laboratories and clinicians need the product, amount and timing information to interpret potentially affected tests.
- There is no evidence-based routine monitoring programme for cosmetic self-use of this injection.
Evidence & sources
Sources are selected for regulatory status, recognised uses and material safety information. They do not validate the HELIX-labelled presentation.
- Barnsley Hospital NHS — Biotin and interference with biochemistry tests
- Peer-reviewed review — Biotin interference in clinical immunoassays
- Health Canada — Biotin and false laboratory test results
- MHRA — Yellow Card adverse-event reporting
Sources accessed and content reviewed 12 September 2026. Regulatory status can change; consult the current official record.
Information disclaimer
HELIX — FOR INFORMATION ONLY. NOT FOR SALE.
The products displayed on this website are presented strictly for informational and educational purposes, helping visitors understand their descriptions, features and specifications. No products are offered for sale through this website, and no product orders or payments are accepted through this platform.
The information on this website does not constitute medical advice, a prescription or a recommendation to use any product. Displaying a product does not establish its regulatory approval, safety or suitability for an individual. Please consult an appropriately qualified healthcare professional for personal medical advice.
For a UK-facing website, this disclaimer does not by itself establish legal compliance. Public advertising of prescription-only medicines and advertising of unlicensed medicines are subject to legal restrictions; the catalogue, wording and presentation require appropriate regulatory review.
Licensed-provider information
Where permitted by applicable law, HELIX may display contact details for independent third-party providers whose registration details have been checked against an appropriate official register. Visitors may contact a listed provider directly to enquire about lawful availability and eligibility requirements.
Any supply is subject to the provider’s assessment, applicable regulations, and verification of all required documentation, which may include a valid prescription, professional licence, identification or other authorisation. A referral does not guarantee availability, eligibility or supply.
Registration status can change. Review the provider's regulator, registration number, official-register record and last-checked date, then verify the current status independently before engaging.